{"id":"topical-minoxidil-5-to-the-scalp","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Scalp irritation"},{"rate":"5-10","effect":"Dryness or flaking"},{"rate":"5-10","effect":"Itching"},{"rate":"1-5","effect":"Hypertrichosis (unwanted hair growth on face/body)"},{"rate":"1-3","effect":"Contact dermatitis"}]},"_chembl":{"chemblId":"CHEMBL802","moleculeType":"Small molecule","molecularWeight":"209.25"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Minoxidil dilates blood vessels in the scalp, improving nutrient and oxygen delivery to hair follicles. It also directly stimulates hair follicle growth by extending the anagen phase and may increase vascular endothelial growth factor (VEGF) production. The exact mechanism of action in androgenetic alopecia remains incompletely understood, but these vascular and follicle-stimulating effects promote hair regrowth and slow hair loss.","oneSentence":"Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:12.758Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Androgenetic alopecia (male and female pattern hair loss)"}]},"trialDetails":[{"nctId":"NCT07459933","phase":"PHASE4","title":"Topical Methotrexate vs Minoxidil for Localized Alopecia Areata","status":"NOT_YET_RECRUITING","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2026-03-15","conditions":"Alopecia Areata","enrollment":268},{"nctId":"NCT07373054","phase":"NA","title":"Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic Alopecia","status":"RECRUITING","sponsor":"Fujian Medical University Union Hospital","startDate":"2025-11-06","conditions":"Androgenic Alopecia","enrollment":18},{"nctId":"NCT07370519","phase":"PHASE2","title":"Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen People's Hospital","startDate":"2026-01-25","conditions":"Androgenetic Alopecia (AGA)","enrollment":388},{"nctId":"NCT07203599","phase":"PHASE1, PHASE2","title":"A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes","status":"RECRUITING","sponsor":"Shenzhen People's Hospital","startDate":"2025-09-20","conditions":"Androgenic Alopecia","enrollment":59},{"nctId":"NCT06556056","phase":"NA","title":"An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)","status":"COMPLETED","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2024-06-30","conditions":"Androgenic Alopecia","enrollment":108},{"nctId":"NCT06813963","phase":"PHASE4","title":"Minoxidil for Treating White Hair: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Southern Medical University, China","startDate":"2025-02-15","conditions":"Grey Hair","enrollment":100},{"nctId":"NCT06015516","phase":"PHASE1","title":"Bioavailability Clinical Trial of Oral Minoxidil 1 mg","status":"COMPLETED","sponsor":"Industrial Farmacéutica Cantabria, S.A.","startDate":"2024-02-09","conditions":"Healthy","enrollment":14},{"nctId":"NCT06552039","phase":"NA","title":"Proof-of-Science, Prospective, Interventional, Three-arm, Double-Blind, Randomized, Safety and Efficacy Real World Evidence Study.","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2024-08-24","conditions":"Hair Fall and Pre-mature Graying","enrollment":99},{"nctId":"NCT06218394","phase":"NA","title":"Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-12-14","conditions":"Androgenetic Alopecia","enrollment":135},{"nctId":"NCT06066827","phase":"NA","title":"Hair Regeneration in Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Dr. dr. Lili Legiawati, SpKK(K)","startDate":"2023-08-14","conditions":"Androgenetic Alopecia","enrollment":60},{"nctId":"NCT05827991","phase":"NA","title":"A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2022-03-01","conditions":"Androgenic Alopecia","enrollment":75},{"nctId":"NCT05681897","phase":"NA","title":"Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Indonesia University","startDate":"2023-02","conditions":"Alopecia, Androgenetic","enrollment":30},{"nctId":"NCT05369481","phase":"NA","title":"Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia","status":"UNKNOWN","sponsor":"Mohammed Abd El Mawgoud Amer","startDate":"2022-03-01","conditions":"Androgenic Alopecia","enrollment":50},{"nctId":"NCT03488108","phase":"PHASE1, PHASE2","title":"Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-01-23","conditions":"Alopecia","enrollment":20},{"nctId":"NCT03753113","phase":"PHASE3","title":"Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%","status":"COMPLETED","sponsor":"Farid Masoud","startDate":"2018-11-28","conditions":"Androgenetic Alopecia","enrollment":24},{"nctId":"NCT01226459","phase":"PHASE3","title":"Clinical Trial in Females for Female Pattern Hair Loss","status":"COMPLETED","sponsor":"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.","startDate":"2010-09","conditions":"Androgenetic Alopecia","enrollment":404},{"nctId":"NCT02154503","phase":"PHASE1","title":"Evaluating the Efficacy of Microneedling in the Treatment of Androgenetic Alopecia","status":"UNKNOWN","sponsor":"Vancouver General Hospital","startDate":"2014-04","conditions":"Androgenetic Alopecia","enrollment":20},{"nctId":"NCT01145625","phase":"PHASE3","title":"Clinical Trial in Females With Female Pattern Hair Loss","status":"COMPLETED","sponsor":"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.","startDate":"2010-06","conditions":"Alopecia","enrollment":322}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":17,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Topical Minoxidil（5%） to the scalp.","genericName":"Topical Minoxidil（5%） to the scalp.","companyName":"Southern Medical University, China","companyId":"southern-medical-university-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle. Used for Androgenetic alopecia (male and female pattern hair loss).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}